Kosan BioSciences -- KOSN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (924)	5/29/2008 1:03:30 PM
From: Icebrg	Read Replies (2) of 933

>>What sort of royalty, etc., for cris?>> I really have no idea. But royalties shouldn't be very high. DNA has been taking the compound all the way from preclinical. On the other hand, if the anti-hedghog platform is validated there should be more compounds of interest with CRIS. CRIS has a market cap these days of around 90 mUSD, around 35 mUSD in cash and no long-term debt. Should be easy to munch. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next